Health Care Delivery

Latest News


CME Content


The disclosure that a calculation error caused the Obama administration to add an extra 400,000 people to ACA enrollment figures for months puts a dent in the 2015 open enrollment, in part because it fits a narrative of a lack of transparency for reporters who cover the administration.

Researchers at Vanderbilt University Medical Center have used electronic health record analysis to uncover hidden drug benefits, according to a study appearing in the Journal of the American Medical Informatics Association.

In March, the Obama administration released guidance extending the renewal of health insurance policies that do not meet the Affordable Care Act's coverage standards through October 1, 2016. At least 9 states that did not adopt the administration's original transitional policy are now allowing renewals of noncompliant policies after January 1, 2014.

A new study shows only a small share of patients with private insurance who were newly diagnosed with diabetes in 2011-2012 enrolled in self-management training, raising questions about how well managed care could address both long-term health and cost control for this important group. These patients are a target for special attention under the ACA.

Following the Supreme Court's decision to hear an appeal for the ACA subsidy lawsuit King v Burwell, a DC appeals court has halted work on a similar case it was reviewing.

More than a year after its disastrous debut, the federal website HealthCare.gov reopened last night, giving shoppers a few days to browse ahead of the November 15 start date for open enrollment, when consumers will have 60 days to make changes or, for some, select first-time coverage under the Affordable Care Act.

Amidst discussions on liver care, transplants, and infections was a session on Value-Based Medicine in Hepatology, on the third day at The Liver Meeting 2014, an annual event by the American Association for the Study of Liver Disease, held in Boston, Massachusetts, from November 7 to 11, 2014. Presenters saw a huge turnout for the session, a sign of increased interest in value-based care.

Three days after the Republican Party gained control of the US Senate and rose to 250 seats in the House of Representatives, the airwaves are filled with bluster aimed at respective bases over what will become of the Affordable Care Act (ACA). While experts from both sides of the aisle agree that a full repeal is unlikely, 1 item has shown up on almost every early list of elements unlikely to survive the next Congress: the medical device tax.

At this time, the Supreme Court of the United States has declined to hear an appeal of one of the cases challenging the legality of making subsidies under the Affordable Care Act available to consumers on the federally run health insurance exchanges.

The war of words between managed care and pharmaceutical manufacturers, which began when Gilead set the price for its drug to treat the hepatitis C virus (HCV), has taken off in October with the reclassification of a trio of cancer drugs from Genentech. Growth in the "specialty pharma" sector, where prices are rising much faster than drug prices generally, has drawn concern from payers and the umbrella group that represents them, while the trade group that represents drugmakers is pushing back against critics, saying that it faces challenges in bringing life-saving therapies to market.

An article in the Journal of the American Medical Association outlines what both CMS and the Pioneer ACOs have learned in the early years of the program, such as the importance of engaging primary care physicians, not growing too quickly, and the need to find better ways to count which patients are in the ACO.

The Institute of Medicine announced yesterday that A. Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care and a national leader in efforts to reform healthcare reimbursement strategies, is among 70 new members elected to the prestigious body.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo